Stay updated on Dupilumab for Eosinophilic Gastritis Clinical Trial
Sign up to get notified when there's something new on the Dupilumab for Eosinophilic Gastritis Clinical Trial page.

Latest updates to the Dupilumab for Eosinophilic Gastritis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAccess to the NCT03678545 study record now shows a 403 Forbidden error, replacing the full trial content. This indicates an access restriction rather than a substantive update to the study data.SummaryDifference19%

- Check17 days agoChange DetectedRevision label on the page was updated from v3.6.6 to v3.7.0, indicating a maintenance update to the page. This change does not modify the clinical trial information or other substantive content.SummaryDifference0.1%

- Check31 days agoChange Detected- The page's revision tag was bumped to v3.6.6, replacing the previous v3.6.5. This indicates a backend or template update rather than a modification to the study details or visible content.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, indicating a new page release. No study data or user-facing content is changed.SummaryDifference0.0%

- Check67 days agoChange DetectedAdded a final citation for the DEGAS publication in Lancet Gastroenterol Hepatol 2026 to the Publications section, replacing the previous online-ahead-of-print citation.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page’s revision tag was updated from v3.6.3 to v3.6.4, signaling a newer backend revision. This change does not alter study content, layout, or user-facing functionality.SummaryDifference0.0%

Stay in the know with updates to Dupilumab for Eosinophilic Gastritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab for Eosinophilic Gastritis Clinical Trial page.